Credit Suisse’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.15M | Buy |
51,113
+3,115
| +6% | +$131K | ﹤0.01% | 1800 |
|
|
2023
Q4 | $1.9M | Buy |
47,998
+7,209
| +18% | +$286K | ﹤0.01% | 1910 |
|
|
2023
Q3 | $1.12M | Sell |
40,789
-10,081
| -20% | -$277K | ﹤0.01% | 2224 |
|
|
2023
Q2 | $1.73M | Buy |
50,870
+14,616
| +40% | +$496K | ﹤0.01% | 2001 |
|
|
2023
Q1 | $1.3M | Buy |
36,254
+2,439
| +7% | +$87.8K | ﹤0.01% | 2146 |
|
|
2022
Q4 | $1.51M | Sell |
33,815
-341
| -1% | -$15.2K | ﹤0.01% | 2033 |
|
|
2022
Q3 | $960K | Buy |
34,156
+4,249
| +14% | +$119K | ﹤0.01% | 2346 |
|
|
2022
Q2 | $806K | Buy |
29,907
+975
| +3% | +$26.3K | ﹤0.01% | 2516 |
|
|
2022
Q1 | $986K | Buy |
28,932
+827
| +3% | +$28.2K | ﹤0.01% | 2546 |
|
|
2021
Q4 | $1.09M | Sell |
28,105
-2,059
| -7% | -$79.6K | ﹤0.01% | 2532 |
|
|
2021
Q3 | $1.63M | Buy |
30,164
+3,742
| +14% | +$202K | ﹤0.01% | 2281 |
|
|
2021
Q2 | $883K | Sell |
26,422
-22,532
| -46% | -$753K | ﹤0.01% | 2714 |
|
|
2021
Q1 | $1.01M | Sell |
48,954
-18,838
| -28% | -$388K | ﹤0.01% | 2575 |
|
|
2020
Q4 | $1.19M | Buy |
+67,792
| New | +$1.19M | ﹤0.01% | 2469 |
|
|
2020
Q2 | – | Sell |
-35,317
| Closed | -$58K | – | 3295 |
|
|
2020
Q1 | $58K | Buy |
+35,317
| New | +$58K | ﹤0.01% | 3272 |
|
|
2018
Q2 | – | Sell |
-18,739
| Closed | -$655K | – | 3494 |
|
|
2018
Q1 | $655K | Buy |
18,739
+652
| +4% | +$22.8K | ﹤0.01% | 2809 |
|
|
2017
Q4 | $771K | Buy |
18,087
+2,511
| +16% | +$107K | ﹤0.01% | 2700 |
|
|
2017
Q3 | $669K | Buy |
15,576
+4,107
| +36% | +$176K | ﹤0.01% | 2907 |
|
|
2017
Q2 | $425K | Sell |
11,469
-4,736
| -29% | -$175K | ﹤0.01% | 2883 |
|
|
2017
Q1 | $877K | Buy |
16,205
+9,446
| +140% | +$511K | ﹤0.01% | 2613 |
|
|
2016
Q4 | $359K | Sell |
6,759
-8,736
| -56% | -$464K | ﹤0.01% | 3221 |
|
|
2016
Q3 | $938K | Sell |
15,495
-1,035
| -6% | -$62.7K | ﹤0.01% | 2699 |
|
|
2016
Q2 | $1.09M | Sell |
16,530
-16,257
| -50% | -$1.07M | ﹤0.01% | 2573 |
|
|
2016
Q1 | $1.86M | Buy |
32,787
+17,827
| +119% | +$1.01M | ﹤0.01% | 2021 |
|
|
2015
Q4 | $3.52M | Buy |
14,960
+3,727
| +33% | +$877K | ﹤0.01% | 1711 |
|
|
2015
Q3 | $1.78M | Sell |
11,233
-13,128
| -54% | -$2.08M | ﹤0.01% | 2178 |
|
|
2015
Q2 | $9.22M | Buy |
24,361
+5,279
| +28% | +$2M | 0.01% | 1183 |
|
|
2015
Q1 | $7.98M | Buy |
19,082
+458
| +2% | +$191K | 0.01% | 1202 |
|
|
2014
Q4 | $5.1M | Buy |
18,624
+4,701
| +34% | +$1.29M | ﹤0.01% | 1498 |
|
|
2014
Q3 | $2.71M | Buy |
13,923
+3,937
| +39% | +$765K | ﹤0.01% | 1940 |
|
|
2014
Q2 | $2.44M | Sell |
9,986
-6,488
| -39% | -$1.59M | ﹤0.01% | 2204 |
|
|
2014
Q1 | $4.37M | Buy |
16,474
+6,977
| +73% | +$1.85M | ﹤0.01% | 1630 |
|
|
2013
Q4 | $3.45M | Buy |
9,497
+5,522
| +139% | +$2.01M | ﹤0.01% | 1851 |
|
|
2013
Q3 | $2.11M | Sell |
3,975
-1,826
| -31% | -$970K | ﹤0.01% | 1999 |
|
|
2013
Q2 | $1.36M | Buy |
+5,801
| New | +$1.36M | ﹤0.01% | 2215 |
|